TSX open
Loading markets…

Advertisement

Stocks

Why Extendicare Inc stock is rising today

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:EXE.TO

Follow EXE

Photos provided by Pexels

Extendicare Inc is seeing a notable rise in its stock price, reflecting positive investor sentiment.

Extendicare Inc (EXE.TO) shares are up 3.04% to CA$27.49 in early trading today. The market is responding positively, likely due to the company's recent financial performance and its ongoing commitment to shareholder returns.

Advertisement

Extendicare Inc

EXE.TO

Full stock page →

EXE.TO

Extendicare Inc

Source:WealthAwesomeWealthAwesome
↓ $1.07 (-3.72%)
120 day period
$26.68$32.66$38.63Apr 17Jul 14Oct 7

Market cap

$2.64B

P/E

21.2x

Div. yield

1.92%

Div. / share

$0.51

52W high

$38.98

52W low

$14.17

1W change

-6.78%

Beta

1.07

Analyst Price Targets

Based on analyst covering EXE · as of Sep 17, 2026

📈

Wall Street analysts forecast EXE stock price to rise 43.3% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$39.83

+43.3% Upside

Current Price

C$27.79

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on EXE's historical volatility

HistoricalForecast68%95%
C$15.41C$20.29C$25.16C$30.04C$34.92C$39.79TodayJun 1Aug 5Oct 7Nov 19Jan 2Feb 14

30-Day Vol

31.8%

Annualized

90-Day Vol

31.6%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$23.25

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$26.18C$23.46 – C$29.23
60 trading daysC$24.67C$21.12 – C$28.82
90 trading daysC$23.25C$19.22 – C$28.12

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Today's rise in Extendicare's stock may signal renewed confidence in the company's operational stability and future growth prospects.

Extendicare's Market Cap Reaches CA$2.54 Billion

With a market cap of CA$2.54 billion, Extendicare's valuation highlights its role as a key player in the healthcare sector, even with recent fluctuations in stock performance.

Bull case

The announcement of a dividend for September 2026, along with a significant increase in adjusted EBITDA in recent quarters, suggests that Extendicare is on solid financial ground. This makes it an appealing option for income-focused investors.

Bear case

Despite today's gains, Extendicare's stock is still down 29.3% from its 52-week high, indicating potential volatility and challenges that investors should keep an eye on.

Positive Market Reaction

Advertisement

Today's rise in Extendicare's stock price can be attributed to several factors, including the recent dividend announcement and the company's strong financial results. Investors likely feel reassured by Extendicare's commitment to returning value to shareholders, which is crucial in the current market environment.

Financial Performance Highlights

Extendicare has shown strong financial performance in recent quarters, with a notable increase in adjusted EBITDA. This growth reflects effective management and operational efficiency, which may boost investor confidence and contribute to today's stock price increase. For more details, check out the latest financial insights on Extendicare's stock page.

Future Outlook

While today's gains are promising, investors should remain cautious given the stock's significant decline from its 52-week high. Keeping an eye on Extendicare's operational developments and market conditions will be essential for making informed investment decisions. For ongoing updates, visit Extendicare's stock page.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 7, 2026
Last Updated: October 7, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement